866-997-4948(US-Canada Toll Free)

Heart Failure Society of America (HFSA) 16th Annual Scientific Meeting - Review and Analysis

Published By :

GlobalData

Published Date : Sep 2012

Category :

Surgical Equipment

No. of Pages : 20


Heart Failure Society of America (HFSA) 16th Annual Scientific Meeting Review and Analysis

GlobalDatas report, Heart Failure Society of America (HFSA) 16th Annual Scientific Meeting Review and Analysis provides key information, analysis and companies with their exhibited products at the HFSA 2012 Conference. The report provides the highlights of the meeting, presentations and key participants with description on their exhibited products. 

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalDatas team of industry experts.

Scope

  • Key players and their exhibited products. 
  • Qualitative analysis on key research presentations. 

Reasons to buy

  • Develop business strategies by understanding the activities and developments at ECR 2012 Conference that can have an impact on the market.
  • Design and develop your product development, marketing and sales strategies 
  • Exploit M&A opportunities by identifying key market players and their products
  • Develop market-entry and market expansion strategies
  • Identify key players best positioned to take advantage of the market opportunities
Table of Contents

1 Table of Contents
1 Table of Contents 1

2 Summary 3

3 Heart Failure Society of America (HFSA) 16th Annual Scientific Meeting Highlights 4
3.1 CircuLite Synergy System Shows Positive Results for Circulatory Support for Elderly Chronic Heart Failure Patients 4
3.1.1 Conclusions and Significance 4
3.2 CircuLite Synergy System Improves Hemodynamics and Exercise Tolerance in Chronic Ambulatory Heart Failure 5
3.2.1 Conclusions and Significance 5
3.3 Cardiac Resynchronization Therapy (CRT) Device Diagnostics can Help Predict Rehospitalization Rate 6
3.3.1 Conclusions and Significance 6
3.4 Cardiac Resynchronization Therapy Optimization Through CardioSync Methodology Compared to Echocardiographic Methodology Found to be Effective in Improving Patient Outcomes 7
3.4.1 Conclusions and Significance 7
3.5 Cardiac Resynchronization Therapy is Beneficial to Patients with Mild to Moderate Heart Failure 8
3.5.1 Conclusions and Significance 8
3.6 Percutaneous Mechanical Support Devices Improve Outcomes for Patients Suffering from Cardiogenic Shock 8
3.6.1 Conclusions and Significance 9
3.7 Researchers find Continuous Flow Pump Therapy Prone to High Rate of Readmission due to Complications 9
3.7.1 Conclusions and Significance 9

4 Key Companies and their Products 10
4.1 ZOLL Medical Corporation 10
4.1.1 LifeVest 10
4.2 Thoratec Corporation 11
4.2.1 HeartMate II LVAS 11
4.2.2 CentriMag 11
4.2.3 PediMag 11
4.3 HeartWare, Inc. 12
4.3.1 HeartWare Ventricular Assist System (VAS) 12
4.4 SynCardia Systems, Inc. 12
4.4.1 SynCardia Temporary Total Artificial Heart 12
4.5 CardiacAssist, Inc. 13
4.5.1 TandemHeart System 13
4.6 BG Medicine, Inc. 13
4.6.1 BGM Galectin-3 Test 13
4.7 Shape Medical Systems, Inc. 14
4.7.1 Shape-HF 14
4.8 XDx, Inc. 14
4.8.1 AlloMap 14

5 Appendix 15
5.1 Acronyms 16
5.2 Sources 17
5.3 Research Methodology 18
5.4 Secondary Research 18
5.5 Primary Research 18
5.6 Models 19
5.7 Forecasts 19
5.8 Expert Panels 19
5.9 GlobalData Consulting 19
5.10 Contact Us 19
5.11 Disclaimer 20

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *

Upcoming Reports